Newsletters - November 1997

Newsletters - November 1997

Andrographis paniculata (N.O. Acanthaceae) is an annual shrub that grows wild in the plains of Asia and in cultivated gardens of North India. This plant has been used as a household remedy in Asia for many centuries. In recent years, clinical trials have validated the use of Andrographis as a successful treatment for the common cold.

The pharmacological effects of the plant are attributed to the presence of the primary active principles, androgarpholide (structure depected below), and its derivatives deoxyandrographolide, neoandrographolide and 14-deoxy-11,12 didehydroandrographolide.

Andrographis paniculata has been used for more than 12 years in Nordic countries for reducing symptoms and the duration of the common cold.

A double blind placebo controlled study performed in Sweden involved the treatment of 50 patients with a herbal preparation containing 85 mg of Andrographis paniculata extract three times daily for five days. As compared to the placebo treated group, patients treated with the herbal preparation had reduced cold symptoms. These patients also reported a greater relief from cold symptoms and took less sick leave from work.

The Andrographis paniculata extract recently introduced to Sabinsa Corporation's extensive product line is standardized to contain a minimum of 10% andrographolides. Samples and specification sheets for this product will be available in early December.

Reference

  • Melchior, J. et al. (1997). Phytomedicine. 3(4) 315-8

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.